Defiance Autism Impact ETF (ASD)
| Assets | $1.41M |
| Expense Ratio | 0.79% |
| PE Ratio | 15.78 |
| Shares Out | 50,000 |
| Dividend (ttm) | $0.01 |
| Dividend Yield | 0.02% |
| Ex-Dividend Date | Jun 24, 2026 |
| Payout Frequency | n/a |
| Payout Ratio | 0.34% |
| Volume | 38 |
| Open | 28.08 |
| Previous Close | 28.26 |
| Day's Range | 28.08 - 28.08 |
| 52-Week Low | 24.59 |
| 52-Week High | 28.52 |
| Beta | n/a |
| Holdings | 41 |
| Inception Date | Jun 1, 2026 |
About ASD
Fund Home PageThe Defiance Autism Impact ETF (ASD) is an exchange-traded fund that is based on the VettaFi Autism Impact index. The fund tracks an equal-weighted index of companies from developed markets supporting individuals on the autism spectrum and broader community. The fund donates profits to organizations focused on autism care, research, and access to resources. ASD was launched on Jun 1, 2026 and is issued by Defiance.
Top 10 Holdings
33.39% of assets| Name | Symbol | Weight |
|---|---|---|
| Definium Therapeutics, Inc. | DFTX | 4.22% |
| Neuren Pharmaceuticals Limited | NEU | 4.21% |
| LifeStance Health Group, Inc. | LFST | 3.38% |
| Otsuka Holdings Co., Ltd. | 4578 | 3.32% |
| ACADIA Pharmaceuticals Inc. | ACAD | 3.27% |
| Anavex Life Sciences Corp. | AVXL | 3.24% |
| Acadia Healthcare Company, Inc. | ACHC | 3.03% |
| BioMarin Pharmaceutical Inc. | BMRN | 3.00% |
| Repligen Corporation | RGEN | 2.96% |
| Revvity, Inc. | RVTY | 2.76% |
Performance
News
How Autism Research ETF ASD Can Deliver for Your Portfolio
ETFs allow investors a plethora of ways to express themselves while also pursuing performance. With each passing year, new ETFs arrive to help investors meet their personal and financial goals.
No Summer Solstice for ETFs: June Records Cap Off a Blockbuster First Half
The arrival of June usually signals a seasonal slowdown for many people, but our ETF industry clearly missed the memo. Instead of heading to the beach or stopping to watch the World Cup, the ETF ecosy...
A Roundup of June's Most Notable ETF Launches
June has seen many ETF launches, from pure-play AI memory chip thematics to an autism impact fund that donates returns to nonprofits. With a record breaking 214 launches, the ETF landscape continues t...
How 2026's Philanthropic ETFs ASD & DUTY Invest
The ETF ecosystem is always changing and growing. Thanks to the ETF's flexibility, transparency, and tradability, it can help investors achieve plenty of bespoke goals.
MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder
SAN FRANCISCO and BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering ...
Defiance Launches the First Autism-Impact ETF (Ticker: ASD), Donating Profits to Autism Causes *
MIAMI, June 02, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs today announced the launch of the Defiance Autism Impact ETF (Ticker: ASD) , the first exchange-traded fund designed to provide targeted exposure...